Table 2.

Adherence in men receiving FDC and concomitant therapy with an α-blocker plus an antimuscarinic

	FDC α-blocker and antimuscarinic	Concomitant therapy
		α-blocker	antimuscarinic
MPR-fixed
N	566	726	726
Mean (SD)	0.91 (0.52)	0.95 (0.37)	0.89 (0.31)
Adherent,a n (%)	453 (80.0)	623 (85.8)	546 (75.2)
MPR-variable
N	566	726	726
Mean (SD)	0.67 (0.31)	0.69 (0.34)	0.64 (0.32)
Adherent,a n (%)	275 (48.6)	358 (49.3)	319 (43.9)
MPR-fixed (persistent men only)
N	313	380	380
Mean (SD)	0.83 (0.21)	0.93 (0.22)	0.85 (0.22)
Adherent,a n (%)	235 (75.1)	324 (85.3)	282 (74.2)

FDC fixed-dose combination, MPR medical possession ratio, SD standard deviation

^aMPR of ≥80%